A genotype of the polymorphic DNA repair gene MGMT is associated with de novo glioblastoma

Neurological Research

Volumn 25, Issue 8, 2003, Pages 875-879

  Inoue, Ryo ^a   Isono, Mitsuo ^a   Abe, Masako ^b   Abe, Tatsuya ^a   Kobayashi, Hidenori ^a  

^a OITA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Brain tumor; Genotype; Glioblastoma; O6 methylguanine DNA methyltransferase; Polymorphism

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; ASTROCYTOMA; DNA REPAIR; EPENDYMOMA; GENE; GENOTYPE; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DNA; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; ODDS RATIO; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0345491859     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103771954005     Document Type: Article

References (26)

1. Böeing H, Schlehofer B, Blettner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 1993; 53: 561-565
2. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc Natl Acad Sci USA 1996; 93: 6941-6946
3. 6-alkylguanine. FASEB J 1992; 6: 2302-2310
4. Sekiguchi M, Nakabeppu Y. Adaptive response: Induced synthesis of DNA-repair enzymes by alkylating agents. Trends Genet 1987; 3: 51-54
5. 6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridization. Mutagenesis 1992; 7: 83-85
6. 6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis. Pharmacogenetics 1996; 6: 361-363
7. Inoue R, Abe M, Nakabeppu Y, Sekiguchi M, Mori T, Suzuki T. Characterization of human polymorphic DNA repair methyltransferase. Pharmacogenetics 2000; 10: 59-66
8. Blin N, Stafford DW. A general method for isolation of high molecular DNA from eukaryotes. Nucleic Acids Res 1976; 3: 2303-2308
9. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, 2nd edn. MA: Cold Spring Harbor Laboratory Press, 1989
10. 6-Alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications. J Neuro Oncol 1994; 21: 135-140
11. Manel E, Jesus GF, Esther A, Steven NG, Oscar FH, Vicente V, Stephen B, James GH. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350-1354
12. 6-methylguanine-DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment? Acta Oncologica 1994; 33: 29-32
13. Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AMF, DiDonato S, Finocchiaro D. Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 1996; 58: 1260-1267
14. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Norden SM, Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993; 92: 169-174
15. Rasheed BKA, Fuller GN, Friedman AH, Darrel D, Bigner DD, Bigner SH. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer 1992; 5: 75-82
16. Li D, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 1997; 57: 2124-2129
17. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947
18. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 1997; 15: 356-362
19. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997; 57: 4183-4186
20. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, Andreas von Deimling, Poustka A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nature Genet 1997; 17: 32-39
21. Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Acquisition of the Glioblastoma Phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol 1999; 55: 387-394
22. Kleihues P, Ohgaki H. Primary and secondary glioblastoma: From concept to clinical diagnosis. Neuro-Oncology 1999; 1: 44-51
23. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994; 81: 427-436
24. Andrea G, Gabriele B, Sonja H, Gerald H, Georg S, Stephan M, Michael M, Christian V, Michael M. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 2000; 87: 434-4371
25. Noll WW, Belloni DR, Rutter JL, Storm CA, Schned AR, Titus-Ernstoff L, Ernstoff MS, Brinckerhoff CE. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol 2001; 158: 691-769
26. Schnakenberg E, Ehlers C, Feyerabend W, Werdin R, Hubotter R, Dreikorn K, Schloot W. Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer. Clin Genet 1998; 53: 396-440